Phenotype standardization for statin-induced myotoxicity.
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis. Research in this area has been hampered to some extent by the lack of standard...
Autores principales: | Alfirevic, A, Neely, D, Armitage, J, Chinoy, H, Cooper, R, Laaksonen, R, Carr, D, Bloch, K, Fahy, J, Hanson, A, Yue, Q, Wadelius, M, Maitland-van Der Zee, A, Voora, D, Psaty, B, Palmer, C, Pirmohamed, M |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2014
|
Ejemplares similares
-
Pharmacogenetics of Statin-Induced Myotoxicity
por: Ping Siu Kee, et al.
Publicado: (2020-10-01) -
DIFFERENTIAL DIAGNOSIS BETWEEN STATIN MYOTOXICITY AND INFLAMMATORY MYOSITIS – CASE PRESENTATION
por: Andreea Daniela Tudorancea, et al.
Publicado: (2018-09-01) -
Role of PGC-1-alpha-associated Mitochondrial Biogenesis in Statin-induced Myotoxicity
por: M Panajatovic, et al.
Publicado: (2020-05-01) -
LOCAL ANESTHETIC MYOTOXICITY
por: B. K. Romanov, et al.
Publicado: (2022-05-01) -
Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients
por: Yoon-A Park, et al.
Publicado: (2024-05-01)